We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$41B
AUM Growth
+$146M
(+0.36%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.25%
Top 10 Holdings %
Top 10 Hldgs %
14.19%
Holding
825
New
119
Increased
275
Reduced
226
Closed
119
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$226M |
| 2 |
AGN
Allergan plc
AGN
|
+$166M |
| 3 |
NRF
NorthStar Realty Finance Corp.
NRF
|
+$152M |
| 4 |
Procter & Gamble
PG
|
+$150M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$382M |
| 2 |
AGN
Allergan Inc
AGN
|
+$274M |
| 3 |
CF Industries
CF
|
+$189M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$164M |
| 5 |
ROC
ROCKWOOD HLDGS INC
ROC
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.99% |
| 2 | Technology | 12.21% |
| 3 | Financials | 11% |
| 4 | Industrials | 9.97% |
| 5 | Consumer Discretionary | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RCPT
151
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $79.6M | 0.19% |
482,979
-523,680
| -52% | -$66.3M |
|
152
Target
TGT
$65.6B
| $79.4M | 0.19% |
967,043
+233,000
| +32% | +$18M |
|
153
US Bancorp
USB
$98B
| $78.7M | 0.19% |
1,801,637
+23,237
| +1% | +$1.02M |
|
|
KYNB
154
Kyntra Bio
KYNB
$27.5M
| $78.2M | 0.19% |
99,715
| – | – |
|
|
KRFT
155
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $78M | 0.19% |
895,335
-1,670,000
| -65% | -$110M |
|
156
Texas Instruments
TXN
$255B
| $77.5M | 0.19% |
1,355,100
-55,000
| -4% | -$3.09M |
|
|
TWC
157
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $75.9M | 0.19% |
506,339
-32,500
| -6% | -$4.85M |
|
|
LM
158
DELISTED
Legg Mason, Inc.
LM
| $75.4M | 0.18% |
1,365,800
+1,105,000
| +424% | +$62M |
|
|
SPR
159
DELISTED
Spirit AeroSystems
SPR
| $75.1M | 0.18% |
1,437,958
-1,872,750
| -57% | -$89.6M |
|
|
ESRX
160
DELISTED
Express Scripts Holding Company
ESRX
| $75M | 0.18% |
864,394
-52,000
| -6% | -$4.36M |
|
161
Elevance Health
ELV
$81.6B
| $74.6M | 0.18% |
483,106
-13,000
| -3% | -$1.85M |
|
|
ADXS
162
DELISTED
Advaxis Inc
ADXS
| $74.2M | 0.18% |
342,624
+45,650
| +15% | +$7.02M |
|
163
Accenture
ACN
$99.9B
| $73.9M | 0.18% |
788,700
-5,000
| -0.6% | -$446K |
|
164
TJX Companies
TJX
$176B
| $73.6M | 0.18% |
2,100,602
+484,128
| +30% | +$16.5M |
|
165
Keurig Dr Pepper
KDP
$43B
| $73.2M | 0.18% |
932,630
-165,725
| -15% | -$12.8M |
|
|
PARA
166
DELISTED
Paramount Global Class B
PARA
| $72.8M | 0.18% |
1,201,259
+826,200
| +220% | +$48.3M |
|
167
Blackrock
BLK
$170B
| $71.1M | 0.17% |
194,380
+1,850
| +1% | +$670K |
|
168
Bread Financial
BFH
$4.47B
| $70.4M | 0.17% |
297,838
+178,051
| +149% | +$40.7M |
|
169
Estee Lauder
EL
$30.7B
| $70M | 0.17% |
841,184
-1,350,000
| -62% | -$106M |
|
170
PPG Industries
PPG
$25B
| $69.9M | 0.17% |
620,122
+158,000
| +34% | +$18.1M |
|
171
Humana
HUM
$44B
| $69.9M | 0.17% |
392,760
+163,000
| +71% | +$25.8M |
|
172
Invesco
IVZ
$13B
| $69.9M | 0.17% |
1,761,469
-1,069,000
| -38% | -$41.8M |
|
173
Abbott
ABT
$183B
| $69.7M | 0.17% |
1,504,692
-250,000
| -14% | -$11.5M |
|
174
Liberty Global Class C
LBTYK
$3.49B
| $69.1M | 0.17% |
1,715,083
+401,731
| +31% | +$15.9M |
|
175
Lennox International
LII
$14.5B
| $68.2M | 0.17% |
610,197
+275,072
| +82% | +$28.4M |
|
Similar funds
Adage Capital Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Adage Capital Partners held 825 positions worth $41B, up 0.36% from $40.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q1 2015, closing 119 positions and reducing 226 holdings. Its most notable exit was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $382M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, Adage Capital Partners opened a new position in Medtronic worth $232M.
- Adage Capital Partners's largest Q1 2015 buy was Medtronic: 2,976,347 shares worth $232M.
- Adage Capital Partners added most to Allergan plc in Q1 2015, an estimated $166M increase.
- Adage Capital Partners's biggest Q1 2015 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $164M.
- Adage Capital Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $382M.
- Adage Capital Partners's ten largest holdings make up 14% of its $41B portfolio in Q1 2015.
- Adage Capital Partners opened 119 new positions and closed 119 in Q1 2015.
- Adage Capital Partners's portfolio value rose 0.36% quarter-over-quarter to $41B.
Based on Adage Capital Partners's 13F filing for Q1 2015, filed 15 May 2015.